Author Details

Name: Thomas Reiberger

Affiliations: Division of Gastroenterology and Hepatology, Vienna Hepatic Hemodynamic Lab, Medical University of Vienna, Vienna, Austria.

Publications

• Predicting hepatic decompensation using non-invasive tests in a contemporary multicentre cohort of patients with cACLD.

• Refining the Baveno VII criteria for clinically significant portal hypertension: an individual-patient data meta-analysis.

• Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling study.

• Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD.

• Evolution of spontaneous portosystemic shunts over time and following aetiological intervention in patients with cirrhosis.

• Predicting survival in patients with 'non-high-risk' acute variceal bleeding receiving β-blockers+ligation to prevent re-bleeding.

• Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysis.

• Non-invasive tests for clinically significant portal hypertension after HCV cure.

• Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event.

• Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis.

• Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis.